Persistent Systems kicked off FY27 with its 25th consecutive quarter of revenue growth, delivering $452.4 million in Q1—a 16.1% year-over-year increase and 3.8% sequentially. In constant currency terms, revenue grew 16.5% YoY and 4.1% QoQ. On a reported basis in INR, revenue surged 29.1% YoY to ₹4,303.2 crore. The performance was underpinned by a record quarterly Total Contract Value (TCV) of $1.15 billion, reflecting continued momentum in larger client engagements, including a 6.5-year strategic services agreement with a leading global technology company valued at over $650 million. InvestorPresentations +1
Management highlighted "broad-based momentum across all our industry segments," with key wins in Software, Hi-Tech & Emerging Industries. While specific Q1 FY27 vertical-wise breakdown isn't publicly disclosed, all three operating segments—BFSI, Healthcare & Life Sciences, and Software Hi-Tech—delivered approximately 28-29% YoY revenue growth. BFSI segment margin improved 125 bps YoY to 35.63%, while Healthcare & Life Sciences revenue accelerated to 29.47% YoY from 7.4% in Q3 FY26. North America remains the dominant market, contributing roughly 81%+ of revenue, with Europe representing approximately 8-8.5%. InvestorPresentations +1
The record TCV of $1.15 billion (specifically $1,146.2 million) with Annual Contract Value (ACV) of $536.8 million demonstrates strong client acquisition and retention capabilities. Key wins included driving product development for one of the world's largest IT companies, advancing a global transport technology ecosystem, and accelerating enterprise transformation for a leading cloud security company. In BFSI, wins included modernizing enterprise applications for a global insurance provider and Gen-AI-led reengineering of trade ledger platforms for a multinational bank. While the company doesn't explicitly disclose the split between new client wins and existing client expansions, the record TCV and nature of deals suggest significant contributions from both strategic long-term agreements and new client acquisitions across verticals.
Despite robust revenue growth, profitability faced headwinds. EBITDA margin compressed 274 bps QoQ to 16.19% due to a surge in other expenses and finance costs tied to the Nagarro acquisition. EBIT margin stood at 16.0%, expanding from 15.5% in Q1 FY26, but PAT margin was 11.2% with sequential decline attributed to forex losses. The most significant margin headwind was the dramatic increase in H-1B visa costs—a new wage-weighted selection process and $100,000 supplemental fee created material margin pressure that partially offset the favorable USD/INR currency tailwind of approximately 1.8%. Acquisition-related costs for the Nagarro deal and strategic reinvestment in AI capabilities and GenAI partnerships further pressured near-term earnings. InvestorPresentations +1
Persistent reported apparently conflicting profit metrics: an 8.7% sequential decline in net profit to ₹483 crore from ₹529 crore in Q4 FY26, but a 13.67% YoY growth to ₹483.04 crore. This divergence stems from different comparison periods and one-time items. Q4 FY26 was an exceptionally strong quarter with net profit jumping 33.73% to ₹529.26 crore, likely including significant other income or one-time gains that inflated the base. Q1 FY27 saw normalization with forex losses contrasting with potential forex gains in Q4 FY26. The YoY growth of 13.67% represents more sustainable underlying profit growth, excluding one-time benefits from the exceptional Q4 FY26 base. InvestorPresentations
HSBC maintained a Hold rating on Persistent Systems with a target price of ₹6,560 as of January 2026, reflecting neutral expectations. The broader analyst community's concerns include structural margin headwinds from H-1B visa costs, AI investment cycles, and acquisition integration expenses. Growth deceleration concerns persist, with worries about revenue growth moderating from historical 25-30% levels to potentially low double-digit rates. Valuation concerns are significant—Persistent trades at 46.93x P/E versus a sector average of 30.73x, a premium that requires sustained high growth to justify.
Persistent's Q1 FY27 EBITDA margin of 16.19% trails large-cap leaders like TCS (24% EBIT margin) and Infosys (21%), but is competitive within the mid-cap segment. Coforge delivered superior margin expansion of 285 bps to 20.3% operating margin, demonstrating the potential for AI-driven efficiency gains. The significant valuation premium—P/B of 11.29x versus sector average of 3.3x—creates multiple compression risk if growth moderates or margins remain under pressure. The market expects gradual margin recovery through H2 FY27 as acquisition costs normalize, with long-term aspirations of returning to 16-17% EBIT margins.
Management maintains a 16-17% EBIT margin aspiration for FY27 while explicitly prioritizing growth and capability investment over near-term margin capture. The company is tracking toward a $2 billion annualized revenue run rate by Q4 FY27, with the Nagarro acquisition expected to transform scale and enhance geographic diversification. The strong deal pipeline with record TCV bookings provides robust revenue visibility, but the near-term trade-off between growth investments and margin expansion creates a complex investment thesis. Investors will need to monitor execution closely, particularly around the Nagarro integration and AI capability monetization, as Persistent navigates the challenging balance between sustaining growth momentum and restoring profitability.
